Health News Roundup: Ebola kills doctor in Uganda, first health worker killed in latest outbreak; Amylyx prices newly approved ALS drug at $158,000 per year and more

Health News Roundup: Ebola kills doctor in Uganda, first health worker killed in latest outbreak; Amylyx prices newly approved ALS drug at 8,000 per year and more

Following is a abstract of present health information briefs.
Ebola kills doctor in Uganda, first health worker killed in latest outbreak
A Tanzanian doctor working in Uganda who contracted Ebola has died, the first health worker killed by the illness in the latest outbreak in the nation, Uganda’s health minister mentioned on Saturday. “I remorse to announce that now we have misplaced our first doctor, Dr. Mohammed Ali, a Tanzanian nationwide, 37-year-old Male,” the health minister, Jane Ruth Aceng, tweeted.
Moderna refused China request to disclose vaccine know-how – FT
Moderna Inc has refused at hand over to China the core mental property behind the event of its COVID-19 vaccine, resulting in a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing individuals aware of the matter. The Cambridge, Massachusetts-based pharmaceutical firm turned down China’s request at hand over the recipe for its mRNA vaccine due to business and security considerations, the newspaper mentioned, citing individuals concerned in negotiations that came about between 2020 and 2021, including that the vaccine maker continues to be “keen” to promote the product to China.
Amylyx prices newly approved ALS drug at $158,000 per year
Amylyx Pharmaceuticals Inc on Friday set the checklist worth of its newly approved drug to deal with amyotrophic lateral sclerosis (ALS) at about $158,000 per year in the United States, a reduction to its most just lately approved competitor. The drug Relyvrio was approved by the U.S. Food and Drug Administration on Thursday, making it the third ALS therapy to get the regulator’s nod after Japanese agency Mitsubishi Tanabe’s Radicava, priced at round $170,000 per year, and the generic drug riluzole.
Cholera kills at least seven in Haiti as illness returns
Haiti on Sunday mentioned at least seven individuals have died of cholera in a shock return of the illness that comes because the nation is paralyzed by a gang blockade that has triggered shortages of gas and clear consuming water. The illness killed some 10,000 individuals via a 2010 outbreak that has been blamed on a United Nations peacekeeping drive. The Pan American Health Organization in 2020 mentioned Haiti had gone a year with no confirmed cholera circumstances. (With inputs from businesses.)

https://www.devdiscourse.com/article/health/2200107-reuters-health-news-summary

Recommended For You